PartsSource Unveils New Visual Formulary Controls and Supply Chain Risk Monitor to Help Clients Improve Equipment Uptime and Supply Chain Resiliency

Breakthrough Technologies Institutionalize Evidence-Based Decisions for HTM and Supply Chain Leaders

PartsSource, the leading online marketplace for medical equipment maintenance parts and services, unveils significant expansions to PartsSource Pro the company’s flagship solution and industry’s first and only clinical resource management platform. Visual Formulary Controls and the Supply Chain Risk Monitor will be leveraged by the 1,500 member hospitals within the PartsSource Pro community. These new capabilities, powered by PartsSource PRECISION Procurement®, will be demonstrated by PartsSource subject matter experts at booth #227 at the Association for the Advancement of Medical Instrumentation® (AAMI) Exchange in San Antonio, Texas.

Control Variance System-Wide with Data-Driven Visual Formularies

Most hospitals source, order, manage and reconcile 200 to 700 different replacement parts and are spending 10% to 30% more on medical devices and replacement parts than necessary due to cost variance.1 Supply chain and HTM leaders need greater visibility to make informed, data-driven decisions and the ability to forecast savings in one platform.

PartsSource Pro’s new Visual Formulary Controls provides the evidence-based data and recommendations for healthcare organizations to implement digital purchasing policies to streamline the procurement process and improve supply chain reliability, while reducing cost variance and enabling clients to:

Make informed decisions: Evaluate supply options and understand tradeoffs across quality, deliverability and cost.
Improve efficiency: View purchase recommendations informed by over three billion data points and standardize procurement preferences at the system, facility, supplier and modality levels.
Simplify program management: View Formulary program savings-to-date and utilize recommendations to further increase savings. Formulary controls have proven to yield upwards of 40% annual cost savings and higher on select modalities, depending on the health system size and scope of implementation.
Improve Supply Chain Visibility and Resiliency with the Supply Chain Risk Monitor

As healthcare technology leaders face global supply chain disruptions, PartsSource provides technology-enabled insights to secure mission-critical supplies and ensure clinical availability and patient safety.

Gain macro and micro visibility into risk: View relative supplier performance trends, benchmarks from peer hospitals across the country and evidence-based data necessary to mitigate impact.
Reduce impact of disruptions: Utilize secondary buying options, stocking strategies and formulary rules to mitigate risks and manage trade-offs.
Identify proactive strategies: Use the data in planning conversations with account management to explore opportunities such as expanded Guaranteed Stock and strategic Preventative Maintenance adjustments.
“With the ongoing supply chain disruptions that our hospital and the broader industry are facing, the solutions and support provided through our PartsSource Pro membership have helped mitigate the impact. The expanded data views coming through Visual Formulary Controls and Visual Analytics will enable me to see supply chain risks and equip me with the data required to evaluate tradeoffs between high quality alternative buying options,” said Jamie Elderkin, Director of Biomedical Engineering, Bassett Healthcare Network.


Promote Efficiency with New Operations Dashboard Manager Views

The Operations Dashboard leverages data to help clinical engineering managers drive better daily management and prioritization of activities to improve equipment uptime and operational efficiency.
Managers can now easily view order updates, backorder status, shipping information and critical hard-down data in one place. In addition to reducing the time spent viewing multiple data sources, the dashboard provides exchange reminders to reduce costs and avoid penalties.
Improve Decision Quality and Reduce Costs with Visual Analytics

Visual Analytics automates the identification of cost-savings opportunities and helps leaders evaluate performance with visibility to spend data, hard cost savings to-date, performance versus program goals and opportunities to save on shipping charges through order consolidation.
The expanded dashboards also simplify active quality management with visibility to quality return rate by supplier and modality, on-time delivery rate by vendor and frequency of delayed shipments by source.
“We know technology has the power to institutionalize data-driven decision making. As PartsSource Pro drives the digital transformation of the medical device supply chain, we will continue to provide our clients with increased visibility to the evidence-based data required to improve asset uptime and supply chain resiliency, while empowering measurable operational and financial outcomes for the healthcare industry,” said Philip Settimi, MSE, MD, President and CEO of PartsSource.

About PartsSource®: Ensuring Healthcare is Always On®

PartsSource’s proprietary procurement platform eliminates friction from the healthcare supply chain by delivering evidence‐based decision support for healthcare technology management (HTM). Through integrated workflows and standardized processes, PartsSource empowers HTM teams to make data-driven decisions, manage long‐tail spend, increase equipment uptime and track the quality of clinical assets. To learn more about the value of proactively managing the lifecycle of clinical resources, visit

The PartsSource Logo, Ensuring Healthcare is Always On and Precision Procurement are registered trademarks of PartsSource, Inc.

1 Behm, Jason, et al. Reducing Cost Variance and Increasing Quality Across Medical Device Maintenance Purchasing. Journal of Clinical Engineering. Vol 46(2):94-97, April/June 2021.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.
"Exact Sciences is looking forward to presenting new evidence at SABCS that adds important perspectives to treating breast cancer patients and showing that some patients may be able to de-escalate treatments and still have positive outcomes," said Dr. Rick Baehner, Chief Medical Officer, Precision Oncology, Exact Sciences. "Every year, we build upon the precedent set by the Oncotype DX Breast Recurrence Score® test and its prognostic and predictive abilities to determine the chemotherapy benefit for specific breast cancer patients. We are pleased to see authorities expanding access to this test as we continue to develop key evidence in collaboration with some of the world's most prestigious, breast cancer-focused organizations."
Clozapine has been established as the most effective antipsychotic medication for treatment-resistant schizophrenia. However, it is significantly underutilized mainly due to the risk of developing agranulocytosis and the need to frequently monitor the absolute neutrophil count (ANC).
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership's significance: "By Integrating our technology to oxygenate blood directly with Ennocure's infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology."
The findings suggest that the novel, non-invasive genomic test can help physicians guide next steps for these patients, enabling them to potentially avoid unnecessary invasive procedures or accelerate time to appropriate treatment.

By using this website you agree to accept Medical Device News Magazine Privacy Policy